Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1248385.RAHRCltR7ehYmw-KgR7iSjcOWfdLt_OZo4M_doRZrK-bo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1248385.RAHRCltR7ehYmw-KgR7iSjcOWfdLt_OZo4M_doRZrK-bo130_assertion type Assertion NP1248385.RAHRCltR7ehYmw-KgR7iSjcOWfdLt_OZo4M_doRZrK-bo130_head.
- NP1248385.RAHRCltR7ehYmw-KgR7iSjcOWfdLt_OZo4M_doRZrK-bo130_assertion description "[Univariate analysis showed that COX-2 protein expression was associated with shorter disease-free survival (DFS) (P = 0.0001), metastasis-free survival (MFS) (P = 0.002) as well as breast cancer specific overall survival (OS) (P = 0.043).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1248385.RAHRCltR7ehYmw-KgR7iSjcOWfdLt_OZo4M_doRZrK-bo130_provenance.
- NP1248385.RAHRCltR7ehYmw-KgR7iSjcOWfdLt_OZo4M_doRZrK-bo130_assertion evidence source_evidence_literature NP1248385.RAHRCltR7ehYmw-KgR7iSjcOWfdLt_OZo4M_doRZrK-bo130_provenance.
- NP1248385.RAHRCltR7ehYmw-KgR7iSjcOWfdLt_OZo4M_doRZrK-bo130_assertion SIO_000772 25511800 NP1248385.RAHRCltR7ehYmw-KgR7iSjcOWfdLt_OZo4M_doRZrK-bo130_provenance.
- NP1248385.RAHRCltR7ehYmw-KgR7iSjcOWfdLt_OZo4M_doRZrK-bo130_assertion wasDerivedFrom befree-2016 NP1248385.RAHRCltR7ehYmw-KgR7iSjcOWfdLt_OZo4M_doRZrK-bo130_provenance.
- NP1248385.RAHRCltR7ehYmw-KgR7iSjcOWfdLt_OZo4M_doRZrK-bo130_assertion wasGeneratedBy ECO_0000203 NP1248385.RAHRCltR7ehYmw-KgR7iSjcOWfdLt_OZo4M_doRZrK-bo130_provenance.